Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

122.26USD
21 Apr 2017
Change (% chg)

$-1.01 (-0.82%)
Prev Close
$123.27
Open
$123.55
Day's High
$123.78
Day's Low
$121.71
Volume
2,913,961
Avg. Vol
3,850,024
52-wk High
$127.64
52-wk Low
$94.42

All Insider Trades
Trading Date Name Title Type Shares Traded Price
9 Apr 2017

Hugin (Robert J)

Officer and Director Buy 60,000 $29.02
29 Mar 2017

Kaplan (Gilla)

Director Sell 14,033 $123.83
2 Mar 2017

Kaplan (Gilla)

Director Buy 7,500 $25.58
28 Feb 2017

Vessey (Rupert)

Officer Sell 4,000 $124.42
26 Feb 2017

Casey (Michael D)

Director Buy 7,500 $25.58
26 Feb 2017

Casey (Michael D)

Director Sell 7,500 $121.55
13 Feb 2017

Kellogg (Peter N)

Chief Financial Officer Sell 7,617 $117.02
13 Feb 2017

Masoudi (Gerald)

General Counsel Buy 5,891 $0.00
13 Feb 2017

Alles (Mark J)

Chief Executive Officer Sell 6,643 $117.02
13 Feb 2017

Kellogg (Peter N)

Chief Financial Officer Buy 14,684 $0.00
13 Feb 2017

Alles (Mark J)

Chief Executive Officer Buy 14,447 $0.00
13 Feb 2017

Masoudi (Gerald)

General Counsel Sell 3,066 $117.02
1 Feb 2017

Vessey (Rupert)

Officer Sell 1,995 $115.54
1 Feb 2017

Vessey (Rupert)

Officer Buy 5,623 $0.00
11 Jan 2017

Casey (Michael D)

Director Gift 84 $0.00
10 Jan 2017

Casey (Michael D)

Director Gift 84 $0.00
4 Jan 2017

Hugin (Robert J)

Officer and Director Buy 22,708 $27.43
28 Dec 2016

Casey (Michael D)

Director Gift 862 $0.00
22 Dec 2016

Casey (Michael D)

Director Gift 593 $0.00
22 Dec 2016

Smith Scott Andrew

Officer Buy 6,400 $0.00
22 Dec 2016

Smith Scott Andrew

Officer Sell 3,318 $118.93
1 Dec 2016

Pehl (Michael F)

Officer Sell 892 $117.63
1 Dec 2016

Alles (Mark J)

Chief Executive Officer Buy 6,560 $0.00
1 Dec 2016

Smith Scott Andrew

Officer Sell 1,944 $117.63
1 Dec 2016

Pehl (Michael F)

Officer Buy 1,880 $0.00

Institutional Holders

% Shares Owned: 80.59%
# of Holders: 1,807
Total Shares Held: 626,993,677
3 Mo. Net Change: 2,765,310
# New Positions: 24
# Closed Positions: 7
# Increased Positions: 141
# Reduced Positions: 121
# Net Buyers: 20

Officers & Directors

Name Age Since Current Position

Robert Hugin

61 2016 Executive Chairman of the Board

Scott Smith

54 2017 President, Chief Operating Officer

Mark Alles

57 2016 Chief Executive Officer, Director

Peter Kellogg

60 2014 Chief Financial Officer, Executive Vice President

Terrie Curran

48 2017 President, Global Inflammation & Immunology Franchise

Thomas Daniel

62 2016 Chairman - Celgene Research

Rupert Vessey

2016 President - Research and Early Development

Gerald Masoudi

48 Executive Vice President, General Counsel and Corporate Secretary

Michael Casey

70 2007 Lead Independent Director

Michael Bonney

57 2015 Director

Jacqualyn Fouse

55 2017 Director

Julia Haller

61 2015 Director

Richard Barker

67 2012 Independent Director

Carrie Cox

59 2009 Independent Director

Michael Friedman

73 2011 Independent Director

Gilla Kaplan

69 1998 Independent Director

James Loughlin

73 2007 Independent Director

Ernest Mario

77 2007 Independent Director